Analyst firms · Raymond James · BDX

Raymond James BDX price target and rating history

Becton Dickinson and Company (BDX) · Health Care

Raymond James rates Becton Dickinson and Company (BDX) Mkt Perform with a $305 price target, as of its latest action on May 2, 2025. It has published 3 rating actions on BDX since March 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a BDX price target in the last 12 months, the median target is $191.

Current rating
Mkt Perform
Price target
$305
Median target, all firms
$191
Actions on BDX
3

Every Raymond James rating on BDX

How other firms rate BDX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$242Nov 6, 2026
Wolfe ResearchOutperformOct 20, 2026
UBSBuy$19Jul 28, 2026
Evercore ISIOutperform$180May 4, 2026
Goldman SachsNeutral$167Apr 10, 2026
BarclaysOverweight$202Feb 10, 2026
CitigroupBuy$233Feb 3, 2026

Questions about Raymond James and BDX

What is Raymond James's price target for BDX?
Raymond James's latest stated price target for Becton Dickinson and Company (BDX) is $305, from its action on Jul 24, 2023.
What is Raymond James's rating on BDX?
Raymond James rates BDX Mkt Perform, a neutral rating, as of May 2, 2025.
When did Raymond James last change its view on BDX?
On May 2, 2025, Raymond James downgrades to Mkt Perform from Outperform.
How does Raymond James's BDX target compare with other analysts?
Across 6 firms with a BDX price target in the last 12 months, the median target is $191.

More BDX rating histories

All Raymond James ratingsBDX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.